Q1 FY 2027 delivered 34% revenue growth and 53% EBITDA growth, driven by strong organolithium and battery chemicals performance. Guidance for FY 2027 was raised, with battery business expected to contribute INR 300 crore and base business to surpass INR 1,000 crore.Based on Neogen Chemicals Ltd. [N…
Q1 FY 2027 delivered 34% revenue growth and 53% EBITDA growth, driven by strong organolithium and battery chemicals performance. Guidance for FY 2027 was raised, with battery business expected to contribute INR 300 crore and base business to surpass INR 1,000 crore.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.